Susquehanna International Group, LLP Syndax Pharmaceuticals Inc Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 168,706 shares of SNDX stock, worth $2.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

168,706

Previous 102,027 65.35%

Holding current value

$2.4 Million

Previous $2.09 Million 55.06%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$17.93 - $24.81 $1.2 Million - $1.65 Million	66,679 Added 65.35%	168,706 $3.25 Million
Q2 2024 Aug 15, 2024	SELL	$18.82 - $23.79 $11.9 Million - $15.1 Million	-634,121 Reduced 86.14%	102,027 $2.09 Million
Q1 2024 May 07, 2024	BUY	$19.71 - $24.57 $14 Million - $17.5 Million	711,751 Added 2917.37%	736,148 $17.5 Million
Q4 2023 Feb 14, 2024	SELL	$11.39 - $21.67 $1.05 Million - $2 Million	-92,493 Reduced 79.13%	24,397 $527,000
Q3 2023 Nov 14, 2023	BUY	$14.52 - $21.77 $1.43 Million - $2.14 Million	98,220 Added 526.08%	116,890 $1.7 Million
Q2 2023 Aug 11, 2023	SELL	$19.35 - $22.31 $1.75 Million - $2.02 Million	-90,655 Reduced 82.92%	18,670 $390,000
Q1 2023 May 16, 2023	BUY	$20.66 - $28.98 $1.83 Million - $2.57 Million	88,637 Added 428.45%	109,325 $2.31 Million
Q4 2022 Feb 14, 2023	SELL	$20.64 - $26.24 $730,676 - $928,922	-35,401 Reduced 63.12%	20,688 $526,000
Q3 2022 Nov 14, 2022	BUY	$18.51 - $24.79 $1.04 Million - $1.39 Million	56,089 New	56,089 $1.35 Million
Q1 2022 May 16, 2022	BUY	$14.84 - $22.15 $349,719 - $521,986	23,566 Added 25.75%	115,094 $2 Million
Q4 2021 Feb 14, 2022	SELL	$15.23 - $22.47 $3.69 Million - $5.44 Million	-242,278 Reduced 72.58%	91,528 $2 Million
Q3 2021 Nov 15, 2021	BUY	$13.87 - $19.8 $3.13 Million - $4.47 Million	225,948 Added 209.49%	333,806 $6.38 Million
Q2 2021 Aug 11, 2021	SELL	$13.42 - $25.18 $630,417 - $1.18 Million	-46,976 Reduced 30.34%	107,858 $1.85 Million
Q1 2021 May 17, 2021	BUY	$19.28 - $24.59 $2.81 Million - $3.58 Million	145,684 Added 1592.17%	154,834 $3.46 Million
Q4 2020 Feb 16, 2021	SELL	$15.1 - $26.44 $105,382 - $184,524	-6,979 Reduced 43.27%	9,150 $203,000
Q4 2019 Feb 14, 2020	SELL	$5.43 - $9.22 $102,800 - $174,553	-18,932 Reduced 54.0%	16,129 $142,000
Q3 2019 Nov 14, 2019	SELL	$7.47 - $10.76 $222,762 - $320,873	-29,821 Reduced 45.96%	35,061 $262,000
Q4 2018 Feb 14, 2019	SELL	$3.6 - $8.42 $120,628 - $282,137	-33,508 Reduced 34.06%	64,882 $289,000
Q3 2018 Nov 14, 2018	BUY	$6.33 - $8.08 $622,808 - $794,991	98,390 New	98,390 $795,000

Others Institutions Holding SNDX

# of Institutions

232

Shares Held

90.1M

Call Options Held

1.01M

Put Options Held

692K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $806M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Syndax Pharmaceuticals Inc Transaction History